Search Here...

A new study, “Investigating the Clinical Utility of the Combined Use of Objective and Subjective Measures of ADHD During Treatment Optimization,”  found that objective measurement of attention-deficit/hyperactivity disorder (ADHD) symptoms, measured by QbTest, were more sensitive to medication effects than patient self-rating, at both one-month and six-month follow-up visits. 

Capturing  improvement in twice as many patients


At  the first follow up,  QbTest  activity  and  inattention measures showed significant effect of medication, compared to the ASRS rating scale, that indicated only moderate effect.  

After six months, the  QbTest  captured  86% of  patient’s  treatment effects  compared  with only 37%  of patient’s improvement captured by the ASRS rating scale.   

The associations between  the  QbTest  and subjective measures increased over time,  and  importantly,  improvements  on both measures correlated with improvement in quality-of-life scores. 


QbTest has proven to show highly sensitive measures of treatment effect, which could lead to better treatment decisions, use of other therapies, and the ability to avoid unnecessarily high dos (1)



ADHD test serves as better early indicator of medication effects than rating scales - infographic